New anti-viral COVID pills don’t take the place of the vaccine
December 24, 2021
Updated Jan. 4, 2022
The FDA issued emergency authorization for Pfizer’s Paxlovid and Merck’s molnupiravir for treatment of ...
You are using an outdated browser. Please upgrade to the latest version for the best experience. Upgrade your browser now.